Your browser doesn't support javascript.
loading
No preventive or therapeutic efficacy of infliximab against macrophage activation syndrome due to systemic juvenile idiopathic arthritis.
Kiuchi, Z; Ogura, M; Sato, M; Kamei, K; Ishikura, K; Abe, J; Ito, S.
Afiliación
  • Kiuchi Z; a Department of Nephrology and Rheumatology , National Center for Child Health and Development , Tokyo , Japan.
  • Ogura M; b Department of Paediatrics , Kyorin University School of Medicine , Tokyo , Japan.
  • Sato M; a Department of Nephrology and Rheumatology , National Center for Child Health and Development , Tokyo , Japan.
  • Kamei K; a Department of Nephrology and Rheumatology , National Center for Child Health and Development , Tokyo , Japan.
  • Ishikura K; a Department of Nephrology and Rheumatology , National Center for Child Health and Development , Tokyo , Japan.
  • Abe J; a Department of Nephrology and Rheumatology , National Center for Child Health and Development , Tokyo , Japan.
  • Ito S; c Department of Allergy and Immunology , National Center for Child Health and Development , Tokyo , Japan.
Scand J Rheumatol ; 48(3): 246-248, 2019 05.
Article en En | MEDLINE | ID: mdl-30406708

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Artritis Juvenil / Interferón gamma / Inmunoglobulinas Intravenosas / Interleucina-18 / Síndrome de Activación Macrofágica / Infliximab Tipo de estudio: Diagnostic_studies / Etiology_studies Límite: Child, preschool / Humans Idioma: En Año: 2019 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Artritis Juvenil / Interferón gamma / Inmunoglobulinas Intravenosas / Interleucina-18 / Síndrome de Activación Macrofágica / Infliximab Tipo de estudio: Diagnostic_studies / Etiology_studies Límite: Child, preschool / Humans Idioma: En Año: 2019 Tipo del documento: Article